U.S. Preventive Services Task Force *
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (www.preventiveservices.ahrq.gov).
New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry.
The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies.
Do not screen adults for COPD using spirometry. (Grade D recommendation)
Screening for chronic obstructive pulmonary disease (COPD) using spirometry: clinical summary of a U.S. Preventive Services Task Force (USPSTF) recommendation statement.
For a summary of the evidence systematically reviewed in making this recommendation, the full recommendation statement of Screening for Chronic Obstructive Pulmonary Disease Using Spirometry, and supporting documents, please go to www.preventiveservices.ahrq.gov. *The potential benefit of spirometry-based screening for COPD is prevention of 1 or more exacerbations by treating patients found to have previously undetected airflow obstruction. However, even in groups with the greatest prevalence of airflow obstruction, hundreds of patients would need to be screened with spirometry to defer 1 exacerbation.
Table 1. What the U.S. Preventive Services Task Force Grades Mean and Suggestions for Practice
Table 2. U.S. Preventive Services Task Force Levels of Certainty Regarding Net Benefit
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
U.S. Preventive Services Task Force. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. ;148:529–534. doi: 10.7326/0003-4819-148-7-200804010-00212
Download citation file:
Published: Ann Intern Med. 2008;148(7):529-534.
Chronic Obstructive Airway Disease, Guidelines, Prevention/Screening, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use